Venturing into the no-man's land of the retina in Parkinson's disease.
about
Visual dysfunction in Parkinson's diseaseThe APOSTEL recommendations for reporting quantitative optical coherence tomography studiesApplication of an OCT data-based mathematical model of the foveal pit in Parkinson disease.Retinal Ganglion Cells and Circadian Rhythms in Alzheimer's Disease, Parkinson's Disease, and BeyondThe avascular zone and neuronal remodeling of the fovea in Parkinson disease.Detection of retinal changes in idiopathic Parkinson's disease using high-resolution optical coherence tomography and heidelberg retina tomography.A novel retinal biomarker for Parkinson's disease: Quantifying the foveal pit with optical coherence tomography.Progressive retinal structure abnormalities in multiple system atrophy.Phosphorylated α-synuclein-immunoreactive retinal neuronal elements in Parkinson's disease subjects.Alpha-synuclein modulates retinal iron homeostasis by facilitating the uptake of transferrin-bound iron: Implications for visual manifestations of Parkinson's disease.The retina as an early biomarker of neurodegeneration in a rotenone-induced model of Parkinson's disease: evidence for a neuroprotective effect of rosiglitazone in the eye and brain.From Imaging the Brain to Imaging the Retina: Optical Coherence Tomography (OCT) in Schizophrenia.Spectral-Domain Optical Coherence Tomography as a Potential Biomarker in Huntington's Disease.Impaired contrast sensitivity is associated with more severe cognitive impairment in Parkinson disease.Alterations of the circadian system in Parkinson's disease patients.Optic neuropathies: the tip of the neurodegeneration iceberg.Patterns of Retinal Ganglion Cell Damage in Neurodegenerative Disorders: Parvocellular vs Magnocellular Degeneration in Optical Coherence Tomography Studies.Retinal thinning correlates with clinical severity in multiple system atrophy.Long-Term Intravitreal Ranibizumab as a Potential Additional Risk Factor for Neurodegeneration in Parkinson's Disease: A Case Report.
P2860
Q26740467-597350A2-82C2-4844-AD65-AA3FCD31C931Q26745975-3889F488-A236-4E96-B875-4DF06467097EQ30804742-12D02D44-B909-4407-94E5-9E5B88E03661Q33634088-204C8AFB-4E2B-41BC-B5A7-FCE40E049172Q35115924-00834692-5429-4F20-B9EA-71C8C950AD69Q35744045-869CFE99-FBC7-4888-91E3-F02C4C37D9FAQ35764753-FF9EB9C1-87C5-44E3-939E-DAC1AFFED1FBQ36057067-3FCCCF23-48B8-48AA-B33C-EED45ACE7ED8Q36115621-169BCDDA-63A2-4AE5-9AB3-21FF1F875AECQ38762283-E3253A6B-3E68-4C54-A4DC-094A9E7818ABQ41683709-89FF2E6B-F1F0-41CA-ACD8-2ACF91808D44Q43126101-7D3CCD8E-34A8-4126-BD9D-C076FF211972Q45293191-EE43FE60-79B2-480F-AAAA-5E8AB9818475Q47125047-E3320C38-E078-48ED-9827-EA624B0C6AF9Q48738662-2CDC2EFB-36DC-4AA7-A95E-A8C550E0F60BQ49608453-F4F56690-D687-4047-A33A-F623E2EAEB01Q49761625-932A3984-B807-4448-8474-D54D7276C021Q50609715-DD6864B9-3FAE-4DE5-B11D-382C751A81E5Q55317090-71D95D71-0764-4CE5-B0B6-6299B3777C49
P2860
Venturing into the no-man's land of the retina in Parkinson's disease.
description
article científic
@ca
article scientifique
@fr
articol științific
@ro
articolo scientifico
@it
artigo científico
@gl
artigo científico
@pt
artigo científico
@pt-br
artikel ilmiah
@id
artikull shkencor
@sq
artículo científico
@es
name
Venturing into the no-man's land of the retina in Parkinson's disease.
@en
type
label
Venturing into the no-man's land of the retina in Parkinson's disease.
@en
prefLabel
Venturing into the no-man's land of the retina in Parkinson's disease.
@en
P2093
P2860
P356
P1433
P1476
Venturing into the no-man's land of the retina in Parkinson's disease.
@en
P2093
Ivan Bodis-Wollner
Shahnaz Miri
Sofya Glazman
P2860
P356
10.1002/MDS.25741
P407
P577
2013-12-11T00:00:00Z